Infusion Catheter Market Size, Share, and Trends 2024 to 2034

Infusion Catheter Market (By Type: Thermodilution Catheter, Pressure Monitoring Catheter, Central Venous Catheter, Anesthesia Catheter, Others; By Application: Hospital, Clinic, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032

  • Last Updated : December 2023
  • Report Code : 3583
  • Category : Healthcare

The global infusion catheter market size was estimated at USD 1881.22 million in 2023 and is projected to hit around USD 4620.50 million by 2032, growing at a CAGR of 10.50% during the forecast period from 2023 to 2032.

Infusion Catheter Market Size 2023 To 2032

To Access our Exclusive Data Intelligence Tool with 15000+ Database, Visit: Precedence Statistics

Key Takeaways

  • North America contributed more than 36% of revenue share in 2022.
  • Asia-Pacific is estimated to expand the fastest CAGR between 2023 and 2032.
  • By type, the thermodilution catheter segment has held the largest market share of 31% in 2022.
  • By type, the anesthesia catheter segment is anticipated to grow at a remarkable CAGR of 11.4% between 2023 and 2032.
  • By application, the hospital segment generated over 48% of revenue share in 2022.
  • By application, the clinic segment is expected to expand at the fastest CAGR over the projected period.

Infusion Catheter Market in the U.S. 2023 To 2032

The U.S. infusion catheter market size was valued at USD 474.93 million in 2023 and is expected to reach USD 1,185.62 million by 2032, growing at a CAGR of 10.70% from 2023 to 2032.

U.S. Infusion Catheter Market Size 2023 To 2032

North America has held the largest revenue share of 36% in 2022. North America dominates the infusion catheter market due to robust healthcare infrastructure, a high prevalence of chronic diseases, and strong investments in research and development. The region's advanced medical facilities facilitate the widespread adoption of infusion catheters, particularly in the context of an aging population requiring long-term treatments. Additionally, favorable reimbursement policies, a proactive regulatory environment, and a focus on technological advancements contribute to North America's significant market share, making it a key player in the global infusion catheter market.

Infusion Catheter Market Share, By Region, 2022 (%)

Asia-Pacific is estimated to observe the fastest expansion. Asia-Pacific commands a significant share of the infusion catheter market due to several factors. The region's robust economic growth, coupled with a rising aging population, has led to an increased prevalence of chronic diseases requiring long-term treatments. Additionally, expanding healthcare infrastructure, growing awareness, and government initiatives contribute to the widespread adoption of infusion catheters. Moreover, the infusion catheter market in Asia-Pacific benefits from the presence of key players, strategic collaborations, and a proactive approach to technological advancements, solidifying the region's prominence in the global market.

Infusion Catheter Market Overview

An infusion catheter stands out as a specialized tool in the medical field, purpose-built for the meticulous and targeted delivery of fluids or medications directly into the bloodstream or specific body tissues. Crafted with finesse, it features a slender, flexible tube equipped with a needle or catheter tip, allowing for its adept insertion into veins, arteries, or other designated anatomical sites. The primary function of this catheter is to serve as a conduit, facilitating the precise administration of therapeutic substances be it medications, nutrients, or blood products directly into the body's circulatory system.

Widely embraced in hospitals and clinics, these catheters take center stage in administering treatments like chemotherapy, pain management medications, or nutritional support. Tailored to diverse needs, some infusion catheters are engineered for prolonged usage, while others are designed for short-term requirements. The adoption of infusion catheters empowers healthcare practitioners, offering them the ability to exercise meticulous control over dosage and infusion rates. This not only elevates the effectiveness and safety of medical interventions but also minimizes potential side effects.

Growth Factors

  • Increasing Incidence of Chronic Diseases: The rising prevalence of chronic conditions, such as cardiovascular diseases and cancer, is propelling the demand for infusion catheters in targeted therapies and long-term treatments.
  • Advancements in Technology: Ongoing technological innovations, including the development of smart catheters and improved materials, are enhancing the performance and capabilities of infusion catheters.
  • Aging Population: As the global population ages, there is a growing need for infusion catheters to address age-related health issues, contributing to market expansion.
  • Rising Surgical Procedures: The surge in surgical interventions, particularly in specialties like oncology and pain management, is driving the utilization of infusion catheters for precise drug delivery.
  • Increasing Healthcare Expenditure: Higher healthcare spending, especially in emerging economies, is supporting the adoption of advanced medical devices, including infusion catheters.
  • Expansion of Ambulatory Care Settings: The trend toward outpatient care and ambulatory surgical centers is creating new avenues for infusion catheter use in more diverse medical settings.
  • Patient Preference for Home Healthcare: The growing preference for home-based treatments is fostering the demand for infusion catheters that facilitate the self-administration of medications.
  • Rising Awareness about Minimally Invasive Procedures: Increased awareness and acceptance of minimally invasive procedures are boosting the demand for catheters for their role in less intrusive medical interventions.
  • Government Initiatives for Healthcare Infrastructure: Supportive government policies and investments in healthcare infrastructure are contributing to the accessibility and adoption of infusion catheters.
  • Growing Focus on Personalized Medicine: The trend toward personalized medicine is creating opportunities for infusion catheters tailored to specific patient needs and treatment regimens.
  • Expanding Applications in Pediatric Care: The versatility of infusion catheters is leading to their increased use in pediatric care, addressing unique medical requirements in children.
  • Strategic Collaborations and Partnerships: Collaborations between medical device manufacturers and healthcare providers are fostering innovation and the development of more efficient infusion catheter solutions.
  • Increasing Prevalence of Infectious Diseases: The global impact of infectious diseases is fueling the demand for infusion catheters in the administration of antibiotics and antiviral medications.
  • Emphasis on Home Infusion Therapy: With the emphasis on home-based healthcare solutions, infusion catheters are playing a crucial role in facilitating effective and safe home infusion therapy.
  • Expanding Geriatric Patient Population: The expanding geriatric demographic is creating a sustained demand for infusion catheters to address the unique healthcare needs of the elderly.
  • Rise in Lifestyle-Related Diseases: The increase in lifestyle-related diseases, such as diabetes and obesity, is contributing to the demand for infusion catheters for chronic disease management.
  • Globalization of the Healthcare Industry: The globalization of healthcare services is driving the standardization and adoption of infusion catheters across different regions.
  • Increasing Awareness of Pain Management Therapies: The awareness and recognition of effective pain management solutions are boosting the use of infusion catheters for targeted pain relief.
  • Focus on Outcomes-Based Healthcare: The shift towards outcomes-based healthcare is encouraging the development of infusion catheters that contribute to improved patient outcomes and reduced hospital stays.
  • Demand for Biocompatible Materials: Growing concerns about compatibility and safety are leading to increased demand for infusion catheters made from biocompatible materials, minimizing the risk of adverse reactions.

Infusion Catheter Market Scope

Report Coverage Details
Growth Rate from 2023 to 2032 CAGR of 10.50%
Market Size in 2023 USD 1881.22 Million
Market Size by 2032 USD 4620.50 Million
Largest Market North America
Base Year 2022
Forecast Period 2023 to 2032
Segments Covered By Type and By Application
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Infusion Catheter Market Dynamics


Increasing surgical procedures and expanding ambulatory care

The surge in surgical procedures and the expansion of ambulatory care settings are driving significant demand for infusion catheters in the medical market. Increasing surgical interventions, especially in fields like oncology and pain management, necessitate precise drug delivery during and after procedures. Infusion catheters play a pivotal role in ensuring controlled and targeted administration of medications, contributing to enhanced postoperative care and recovery.

Additionally, the growing prominence of ambulatory care, where patients receive treatments in outpatient settings, underscores the need for efficient and portable infusion solutions. Infusion catheters offer a convenient means to administer medications outside traditional hospital environments, aligning with the trend towards patient-centric, accessible healthcare. The flexibility and versatility of infusion catheters make them vital components in addressing the evolving landscape of modern medical practices, accommodating the demand for effective and minimally invasive solutions in both surgical and ambulatory care scenarios.


Infection risks and stringent regulatory approval

Infection risks and stringent regulatory approval processes significantly impede the market demand for infusion catheters. Concerns about catheter-related infections, especially during prolonged use, pose a substantial barrier to widespread adoption. The potential for infections not only raises patient safety apprehensions but also prompts healthcare providers to explore alternative, less risky drug delivery methods. Moreover, stringent regulatory approval requirements contribute to a prolonged time-to-market for new infusion catheter products.

The rigorous evaluation and approval processes may delay product launches, hindering the timely introduction of innovative catheter technologies into the market. This delay not only restricts industry innovation but also limits the availability of advanced catheters for healthcare professionals and patients seeking more efficient and safer treatment options. The demanding regulatory landscape adds a layer of complexity to the development and commercialization of infusion catheters, with manufacturers grappling with extensive documentation, testing, and compliance measures.

As a consequence, these challenges can impede market access for both established companies and new entrants, leading to a constrained market environment that may struggle to meet the dynamic demands of modern healthcare. The industry must navigate these hurdles collaboratively to address infection risks and streamline regulatory processes, ensuring that infusion catheters can realize their full potential as safe and effective medical devices.


Home healthcare expansion and emerging markets

The expanding landscape of home healthcare and the exploration of emerging markets present significant opportunities for the infusion catheter market. As the healthcare industry increasingly shifts towards decentralized and patient-centric models, infusion catheters designed for home use are becoming pivotal. These catheters offer patients the flexibility to self-administer medications in the comfort of their homes, promoting convenience and potentially reducing healthcare costs associated with in-patient treatments.

The ability to adapt infusion catheter designs to suit home environments and patient preferences positions manufacturers to tap into a rapidly growing market segment, meeting the rising demand for personalized and accessible healthcare solutions.

Moreover, the exploration of emerging markets, particularly in developing economies, opens up new frontiers for the infusion catheter market. Adapting to the unique healthcare landscapes in these regions and tailoring catheter designs to suit diverse needs can create opportunities for market expansion. Manufacturers that strategically navigate these opportunities stand to benefit from increased market share, revenue growth, and the ability to address unmet healthcare needs in previously underserved populations.

Type Insights

In 2022, the thermodilution catheter segment had the highest market share of 31% based on the type. Thermodilution catheters are a type of infusion catheter designed for measuring cardiac output by utilizing the principle of thermodilution. These catheters introduce a known volume of cold saline into the bloodstream, allowing for the calculation of cardiac output based on temperature changes.

A trend in the infusion catheter market is the increasing adoption of thermodilution catheters for real-time hemodynamic monitoring during critical care scenarios, providing healthcare professionals with valuable insights into a patient's cardiovascular status, guiding treatment decisions, and improving overall patient outcomes.

The anesthesia catheter segment is anticipated to expand at a significant CAGR of 11.4% during the projected period. The anesthesia catheter segment in the infusion catheter market refers to specialized catheters designed for the administration of anesthesia during medical procedures. These catheters facilitate precise and controlled delivery of anesthetic agents, ensuring patient comfort and safety.

A notable trend in this segment involves the integration of advanced materials and technology to enhance catheter performance, minimize discomfort, and improve overall efficiency. As medical procedures continue to evolve, the demand for anesthesia catheters that offer optimal anesthesia management and patient experience is expected to rise, driving innovation in this specific category.

Application Insights

According to the application, the hospital segment has held 48% revenue share in 2022. In the context of infusion catheters, the hospital segment refers to the application of these devices within traditional healthcare settings. Hospitals utilize infusion catheters for a diverse range of medical procedures, including surgical interventions, chemotherapy, and pain management.

A prominent trend in this segment involves the integration of advanced technologies into catheter designs, improving precision and monitoring capabilities. Additionally, the adoption of infusion catheters in outpatient settings within hospitals reflects a growing emphasis on providing efficient and targeted treatments while minimizing patient hospitalization periods.

The clinic segment is anticipated to expand fastest over the projected period. In the infusion catheter market, the clinic segment refers to the use of catheters in outpatient clinic settings. Clinics employ infusion catheters for various medical applications, including chemotherapy, pain management, and antibiotic administration.

A notable trend in this segment involves the increasing adoption of ambulatory care, where clinics offer infusion services outside traditional hospital settings. This trend aligns with the broader movement towards patient-centric care, providing a more convenient and accessible environment for individuals to receive infusion therapies in specialized clinic settings.

Recent Developments

  • In March 2021, Medtronic introduced the Chameleon Percutaneous Transluminal Angioplasty (PTA) balloon catheter in select European and African countries, including Germany, Portugal, Italy, South Africa, Turkey, and Spain. This innovative catheter is designed for use in a range of arterial applications, including femoral, iliac, and renal arteries, as well as both native and synthetic arteriovenous dialysis fistulas. The system's approval underscores its versatility and suitability for various vascular interventions, offering healthcare professionals a reliable and effective tool for angioplasty procedures. Medtronic's expansion of its product portfolio reflects ongoing efforts to address diverse clinical needs and enhance treatment options in the field of interventional cardiology and vascular care.

Infusion Catheter Market Players

  • Medtronic
  • B. Braun Melsungen AG
  • Terumo Corporation
  • Johnson & Johnson
  • Becton, Dickinson and Company
  • Teleflex Incorporated
  • Smiths Medical
  • Nipro Corporation
  • C.R. Bard (acquired by Becton, Dickinson and Company)
  • AngioDynamics, Inc.
  • Cook Medical
  • ICU Medical, Inc.
  • Vygon SA
  • Fresenius Kabi AG
  • Merit Medical Systems, Inc.

Segments Covered in the Report

By Type

  • Thermodilution Catheter
  • Pressure Monitoring Catheter
  • Central Venous Catheter
  • Anesthesia Catheter
  • Others

By Application

  • Hospital
  • Clinic
  • Others

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Frequently Asked Questions

The global infusion catheter market size is expected to increase USD 4,620.50 million by 2032 from USD 1,881.22 million in 2023.

The global infusion catheter market will register growth rate of 10.50% between 2023 and 2032.

The major players operating in the infusion catheter market are Medtronic, B. Braun Melsungen AG, Terumo Corporation, Johnson & Johnson, Becton, Dickinson and Company, Teleflex Incorporated, Smiths Medical, Nipro Corporation, C.R. Bard (acquired by Becton, Dickinson and Company), AngioDynamics, Inc., Cook Medical, ICU Medical, Inc., Vygon SA, Fresenius Kabi AG, Merit Medical Systems, Inc., and Others.

The driving factors of the infusion catheter market are the increasing surgical procedures and expanding ambulatory care.

North America region will lead the global infusion catheter market during the forecast period 2023 to 2032.

Proceed To Buy

USD 5400
USD 3800
USD 2100
USD 2100
USD 7500

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client